Ivanoff et al., 1989 - Google Patents
Human immunodeficiency virus antigen.Ivanoff et al., 1989
- Document ID
- 6972277279754370586
- Author
- Ivanoff L
- Petteway S
- Publication year
- Publication venue
- Patent NumberUS Patent 4, 861, 707
External Links
- 241000725303 Human immunodeficiency virus 0 title abstract description 6
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE92502T1 (en) | ENVELOPE ANTIGENS OF HUMAN IMMUNODEFICIENCY VIRUS AND THEIR USES. | |
| ATE154610T1 (en) | SYNTHETIC PEPTIDES DERIVED FROM HIV GP120 ENV PROTEIN AND THEIR APPLICATION | |
| PT101052A (en) | Hybrid proteins useful in the preparation of vaccines | |
| CA2078694A1 (en) | Hepatitis b vaccine | |
| DE3588022D1 (en) | Pre-S gene encoded hepatitis B immunogenic peptides, vaccines, diagnostics and synthetic lipid vesicles. | |
| WO1989002277A3 (en) | Prophylaxis and therapy of acquired immunodeficiency syndrome | |
| FR2670787B1 (en) | LIPOPEPTIDES INDUCING CYTOTOXIC T CELLS AND USE AS VACCINES. | |
| FI885296A0 (en) | RECOMBINANT HIV-2 POLYPEPTIDES. | |
| EP0572737A3 (en) | HIV Gag-env fusion antigen. | |
| WO1993017110A3 (en) | A recombinant hepatitis c virus polypeptide | |
| KR920002629A (en) | Amino Acid Residue Sequence of Hepatitis B Core Antigen | |
| Ivanoff et al. | Human immunodeficiency virus antigen. | |
| KR950005326A (en) | Recombinant Adenovirus Vaccine | |
| CA2160696C (en) | Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus | |
| EP0426314A3 (en) | Hiv related peptides | |
| WO2004067020A1 (en) | Dna vaccine composition with enhanced immunogenicity | |
| WO2002051865A3 (en) | Proteinic antigens inducing antibodies neutralising hiv virus | |
| Andre | Development and clinical studies with a recombinant DNA hepatitis B vaccine | |
| Bayer et al. | Expression of HIV 1 and HIV 2 polypeptides and their use | |
| TH13136A (en) | HIV antigen | |
| WO1991009872A3 (en) | Hiv-1 env fragment fusion protein | |
| PT86752A (en) | NEw peptide(s) with immunological properties of HIV-2 envelope protein - have the structure of simian immune deficiency virus proteins, useful in diagnosis and of vaccine components | |
| TH4070EX (en) | DNA sequence containing the code of P31 seraphase antigen, modified hepatitis B virus. | |
| TH13136EX (en) | HIV antigens |